基于“六经伏毒”理论动态调节原发性肝癌免疫稳态思路
刘静璇 , 赵啸虎 , 刘伟 , 王承祥 , 侯爱画
吉林中医药 ›› 2026, Vol. 46 ›› Issue (9) : 1108 -1113.
基于“六经伏毒”理论动态调节原发性肝癌免疫稳态思路
Dynamic regulation of immune homeostasis in the treatment of primary liver cancer based on the theory of "latent toxins in the six channels"
原发性肝癌(PLC)的疾病进程与免疫编辑主导的免疫状态失衡密切相关,上述动态演变过程与中医学六经传变理论高度契合。据此,侯爱画提出基于“六经伏毒”理论动态调节PLC免疫稳态之学术思想,建立辨病与辨证相结合的PLC免疫稳态调控体系,以期控制毒邪传变、纠正阶段性免疫失衡、截断免疫编辑进程。临证中,侯爱画结合PLC“湿、热、瘀、毒”胶结伏留之病理特征,确立健脾补肾养肝、解毒化瘀软坚之辨病核心治法,并进一步提出从“六经伏毒”辨治PLC不同阶段免疫失衡状态之辨证思路:亚临床早期,重在调和营卫、和畅枢机;亚临床期,旨在和解少阳、疏肝理气;进展期,须解毒软坚、清解阳明;缓解期,可疏肝健脾、化瘀软坚;终末期,宜滋养肝肾、解毒散结。方药以辨病核心方愈肝散结汤结合六经分证配属经方分期论治。
The disease process of primary liver cancer (PLC) is closely related to the immune state imbalance led by immune editing, and the above dynamic process is highly consistent with the theory of transmission and transformation of the six meridians in traditional Chinese medicine. Accordingly, Professor Hou Aihua puts forward the idea of dynamically adjusting PLC immune homeostasis based on the theory of "latent toxins in the six channels", and establishes a PLC immune homeostasis regulation system combining disease differentiation and syndrome differentiation, so as to control the transmission of pathogens, rectify the staged immune unbalanced state and cut off immune editing. Professor Hou Aihua, based on the pathological characteristics of primary liver cancer such as adhering and lingering "dampness, heat, blood stasis and toxin", proposes the core treatment approaches for PLC on the basis of disease differentiation, such as invigorating the spleen, tonifying the kidney and nourishing the liver, detoxifying and removing blood stasis and softening hard masses. Furthermore, he further comes up with the ideas for syndrome differentiation and treatment of immune imbalance in PLC at different stages from the perspective of the "six meridians laten toxins" theory. In the early subclinical stage, his treatment prioritizes harmonizing yingfen and weifen, and restoring smooth flow of the pivot qi. In the sub-clinical stage, his treatment is aimed at harmonizing shaoyang, soothing the liver and regulating qi. In the advanced stage, his treatment is targeted at detoxifying and softening hard masses, and clearing yangming. In the remission stage, his treatment underlines dispersing the liver and strengthening the spleen, resolving blood stasis and softening hard masses. In the final stage, his treatment is advisable to nourish the liver and kidney, detoxify and eliminate hard masses. His core prescription features Yugan Sanjie Decoction based on disease differentiation, paired with classic formulas based on the syndrome differentiation of six channels.
| [1] |
|
| [2] |
中华人民共和国国家卫生健康委员会.原发性肝癌诊疗指南(2026年版)[J].中华外科杂志, 2026, 64(6):549-580. |
| [3] |
|
| [4] |
|
| [5] |
李燕,黄文博,周舒雯, |
| [6] |
曹建恒,李国臣,胡海波, |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
卢泰成,许博文,邬金洋, |
| [11] |
蔡万德,聂金娜. 《伤寒论》对《内经》六经理论的扩充及发展[J]. 上海中医药杂志, 2017, 51(6):33-34. |
| [12] |
惠登城,孙明瑜,刘嘉湘. 刘嘉湘运用疏利少阳法治疗肝癌经验[J]. 国医论坛, 2021, 36(2):56-58. |
| [13] |
张玉萱,蔡丽丽,贾立军. 基于“少阳厥阴”探讨靶向衰老治疗肝癌的理论内涵[J]. 上海中医药杂志, 2024, 58(2):36-39. |
| [14] |
马熙淼,饶卉明,綦鹏, |
| [15] |
刘华生,刘洋,周景华. 柴胡桂枝汤对肝纤维化大鼠TNF-α、CTGF表达的影响[J]. 中医药学报, 2011, 39(6):35-37. |
| [16] |
霍瑞静,张翠丽,李静, |
| [17] |
杨武斌,唐金凤,米本中. 柴胡疏肝散对早期肝纤维化大鼠JAK2/STAT3信号通路的影响[J]. 癌变·畸变·突变, 2022, 34(3):200-205. |
| [18] |
周淑娟,陈岩岩,李琤, |
| [19] |
|
| [20] |
|
| [21] |
廖伟然. 茯苓酸通过上调ANKRD1抑制肝细胞癌的作用及机制研究[D]. 昆明: 昆明医科大学, 2023. |
| [22] |
乔曦,许世豪,王宇炜, |
| [23] |
刘亚楠,吕恬仪,任越, |
| [24] |
肖黄满,尚海涛,张静宇, |
| [25] |
郭旭彤,安继东,梅建强. 柴胡皂苷A对抑郁症大鼠Treg和Th17免疫平衡的影响[J]. 海南医学院学报, 2020, 26(22):1686-1690. |
| [26] |
常彦祥,孙利平. 柴胡皂苷D对肝癌大鼠肿瘤生长和免疫功能的影响[J]. 中国临床药理学杂志, 2020, 36(14):2059-2062. |
| [27] |
|
| [28] |
陈元花,梁虹,陈彦辛, |
| [29] |
谢斌,饶斌,余功, |
| [30] |
王帆.乌梅汤联合靶向及免疫治疗寒热错杂型肝癌的临床观察及情志影响[D].郑州:河南中医药大学, 2024. |
第七批全国老中医药专家学术经验继承项目(国中医药人教函〔2022〕76号)
国家中医药管理局科技司共建科技项目(GZY-KJS-SD-2023-013)
全国名老中医药专家传承工作室(国中医药人教函〔2018〕134号)
山东省名老中医药专家传承工作室(鲁卫函〔2019〕92号)
/
| 〈 |
|
〉 |